Press Releases about Moderna Inc
From Moderna, Inc.
Via AccessWire
Moderna Announces First Participants Dosed in Phase 3 Study of Seasonal Influenza Vaccine Candidate (mRNA-1010)
June 07, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement
June 02, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
Moderna to Present at Upcoming Conferences in June 2022
June 01, 2022
From Moderna, Inc.
Via AccessWire
Topics
Intellectual Property
From Moderna, Inc.
Via AccessWire
Moderna Files for Authorization of Its COVID-19 Vaccine in Young Children Six Months to Under Six Years of Age
April 28, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
Arpa Garay Joins Moderna as Chief Commercial Officer
April 27, 2022
From Moderna, Inc.
Via AccessWire
From Moderna, Inc.
Via AccessWire
Jorge Gomez Joins Moderna as Chief Financial Officer
April 11, 2022
From Moderna, Inc.
Via AccessWire
IAVI and Moderna Partner to Tackle Broad Global Health Priorities Using mRNA for Vaccines and Antibodies
April 07, 2022
From Moderna, Inc.
Via AccessWire
Topics
Death
Moderna Launches New Charitable Foundation
April 04, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
Exposures
COVID-19
From Moderna, Inc.
Via AccessWire
From Moderna, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.